Tolerability and efficacy of isoprodian-containing antituberculosis regimens.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007539:Isonicotinic Acids / Q000627:therapeutic use*; D011515:Prothionamide / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D007539:Isonicotinic Acids; C011004:isoprodian; D011515:Prothionamide; D003622:Dapsone; D007538:Isoniazid